Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 1/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20623017 | 0.90 | GRIA1 (0.37) | TACR1TACR3GRIA1 | |
| SCHEMBL21536833 | 0.86 | GRIA1 (0.37) | TACR1TACR3GRIA1 | |
| SCHEMBL24328660 | 0.83 | KDM4E (0.34) | — | |
| SCHEMBL20623016 | 0.80 | TACR1 (0.33) | TACR1TACR3 | |
| SCHEMBL24823972 | 0.78 | TACR1 (0.32) | TACR1TACR3 | |
| SCHEMBL19756282 | 0.75 | GRIA1 (0.44) | TACR1TACR3GRIA1 | |
| SCHEMBL21285433 | 0.73 | — | — | |
| SCHEMBL19756273 | 0.72 | KDM4E (0.36) | GRIA1 | |
| SCHEMBL22390106 | 0.72 | USP2 (0.34) | TACR1TACR3 | |
| SCHEMBL19115834 | 0.67 | SIRT6 (0.40) | TACR1TACR3GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220118053-A1 | Dry Pharmaceutical Formulations of CNP Conjugates | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220118053-A1 | Dry Pharmaceutical Formulations of CNP Conjugates | CNP, PTMS, NPPA | TACR1 164/4885TACR3 137/4885GRIA1 2197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.